New lung implant could help severe emphysema patients breathe easier
NCT ID NCT07086339
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called the IAB 50 Flex, an implantable artificial bronchus for adults with severe COPD or emphysema. The trial will enroll 20 participants across two hospitals to check if the implant is safe and if it helps improve breathing and daily activity. The main goal is to see if there are any serious side effects related to the device or procedure within 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
implantable pulmonary stent (IAB 50 Flex)
What this could lead to
If successful, this implant could offer a new way to help people with severe emphysema breathe easier and improve daily function.
What could go wrong
This is a very early, small trial (20 people) focused on safety, not yet proven to work. The implant may cause serious side effects or not help breathing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DUPUYTREN University Hospital
RECRUITINGLimoges, 87000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Medical Center Groningen
RECRUITINGGroningen, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••